Safety depends on the platform using licensed, board-certified providers, requiring a thorough medical evaluation, filling prescriptions through licensed pharmacies, requesting appropriate lab work, and providing ongoing follow-up care
Emerging role of SGLT-2 inhibitors for the treatment of obesity
In a 72-week study enrolling 3,172 overweight adults, the highest dose of orforglipron (36 mg) caused 12.4% weight loss
But what could be dismissed as first world problems points to something bigger: Medical revolutions require accompanying revolutions across the health care system and that is not happening with GLP-1s
Sin embargo, junto con el entusiasmo por los resultados rpidos, crecen las advertencias de expertos y pacientes sobre un efecto secundario preocupante: la prdida de masa muscular y la sensacin de debilidad, segn reporta vox
It declines naturally with age and stress